Publisher: Hoodline


Memphis Doctor Training Program at Risk as UT, Regional One Clash Over Money

In the Media Icon

A financial dispute between the University of Tennessee Health Science Center College of Medicine and Regional One Health has put the future of a resident training program in Memphis in question, with UT confirming it will exclude future Regional One resident and fellow rotations from its match program starting in July 2027.


Kelsea Ballerini Brings Musicians On Call Home to Dolly Parton Children’s Hospital

In the Media Icon

Kelsea Ballerini returned to her hometown of Knoxville to launch a new Musicians On Call bedside program at Dolly Parton Children’s Hospital, holding a private performance for children receiving care before helping establish the initiative at the pediatric facility.


Kingsport Chases $10M to Triple Dental Clinic Capacity, Reach More Patients

In the Media Icon

Kingsport is angling for a $10 million state grant that would dramatically expand a dental clinic that has logged thousands of appointments since opening in fall 2024.


Tennessee Sends $206 Million to Rural Health Projects in 44 Counties

In the Media Icon

Fifty-three organizations across 44 rural Tennessee counties are splitting a $206.9 million pot of federal money meant to shore up healthcare that has been eroding for years in small towns from the Cumberland Plateau to the Smokies.


Knoxville Historic Buildings Fuel New Business Growth

In the Media Icon

From faded laundries to former utility offices, Knoxville’s older buildings are back on the clock.


Mid-South Universities Launch AI Research Consortium In Memphis

In the Media Icon

University leaders from four Mid-South institutions are set to put pen to paper on April 20, signing an agreement that creates the Mid-South AI Research Consortium and officially links their AI ambitions.


Dr. James Dale Named Innovator of the Year for Pioneering Strep Vaccine Research

In the Media Icon

Dr. James Dale, professor emeritus at the University of Tennessee, has been recognized for his decades-long work developing a vaccine against Group A streptococcus, the bacteria that causes rheumatic heart disease and claims nearly half a million lives each year.


UT Health Science Center’s Liza Makowski Leads Study on Long-Term Cancer Risks of Popular GLP-1 Obesity Drugs

In the Media Icon

As the obesity epidemic continues to affect the U.S. healthcare system, a new commentary discusses GLP-1 drugs, including Ozempic, Wegovy, and Zepbound, which have become widely used in obesity treatment.